首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial
【2h】

Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial

机译:高渗盐水用于心脏手术后的液体复苏(HERACLES):一项初步的随机对照临床研究的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundIntraoperative and postoperative management of cardiac surgery patients is complex, involving the application of differential vasopressors and volume therapy. It has been shown that a positive fluid balance has a major impact on postoperative outcome. Today, the advantages and disadvantages of buffered crystalloid solutes are a topic of controversy, with no consensus being reached so far. The use of hypertonic saline (HS) has shown promising results with respect to lower total fluid balance and postoperative weight gain in critically ill patients in preliminary studies. However, collection of more data on HS in critically ill patients seems warranted. This preliminary study aims to investigate whether fluid resuscitation using HS in patients following cardiac surgery results in less total fluid volume being administered.
机译:背景技术心脏外科手术患者的术中和术后管理很复杂,涉及差分血管加压药和体积疗法的应用。已经显示出正的液体平衡对术后结果具有重大影响。如今,缓冲的晶体溶质的优缺点已成为一个有争议的话题,迄今为止尚未达成共识。在初步研究中,高渗盐水(HS)的使用在降低重症患者的总液体平衡和术后体重增加方面显示出令人鼓舞的结果。但是,似乎有必要收集更多重症患者的HS数据。这项初步研究旨在调查心脏手术后使用HS进行的液体复苏是否能减少总液体量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号